title: The benefits and risks of over-the-counter availability of levonorgestrel emergency contraception.
abstract: Removing the prescription requirement for Plan B will help ensure that the product plays a larger role nationally in the reduction of unintended pregnancy and abortion-important public health goals. Over-the-counter (OTC) sale of Plan B should present no serious safety issues. OTC consumers are able to understand and follow the instructions for proper use of Plan B. Efficacy of the OTC product is likely to be the same as, or better than, the prescription product, given more timely access to treatment. Based on the results of a growing body of literature and foreign marketing experience, the risk of unintended health consequences also appears to be minimal. There is no evidence to suggest that American women will abuse Plan B as an OTC product.
authors.affiliation: Women's Capital Corporation, 1990 M Street NW, Suite 250, Washington, DC 20036, USA.
authors.forename: S L
authors.initials: SL
authors.lastname: Camp
authors.forename: D S
authors.initials: DS
authors.lastname: Wilkerson
authors.forename: T R
authors.initials: TR
authors.lastname: Raine
mesh_terms: D003280:Contraceptives, Oral, Synthetic / Q000600:supply & distribution*; D003281:Contraceptives, Postcoital / Q000600:supply & distribution*; D005260:Female; D006801:Humans; D007880:Legislation, Drug; D016912:Levonorgestrel / Q000600:supply & distribution*; D004366:Nonprescription Drugs / Q000600:supply & distribution*; D010593:Pharmaceutical Services; D018570:Risk Assessment; D014481:United States
chemical_list: D003280:Contraceptives, Oral, Synthetic; D003281:Contraceptives, Postcoital; D004366:Nonprescription Drugs; D016912:Levonorgestrel